To test for potential dysregulation of GR trafficking in individuals with neurodevelopmental psychiatric conditions, we performed cellular fractionation followed by immunoblot assays with anti-GR antibodies in postmortem frontal cortex samples of schizophrenia subjects and individually matched controls (Tables 2 and 3). This evidence concerns the gene NR3C1 and schizophrenia.